Literature DB >> 27129240

Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage.

Xiangzi Han1, Jinshan Tang2, Jingna Wang1, Feng Ren1, Jinhua Zheng1, Megan Gragg3, Philip Kiser1, Paul S H Park3, Krzysztof Palczewski1, Xinsheng Yao2, Youwei Zhang4.   

Abstract

Phosphorylation of Chk1 by ataxia telangiectasia-mutated and Rad3-related (ATR) is critical for checkpoint activation upon DNA damage. However, how phosphorylation activates Chk1 remains unclear. Many studies suggest a conformational change model of Chk1 activation in which phosphorylation shifts Chk1 from a closed inactive conformation to an open active conformation during the DNA damage response. However, no structural study has been reported to support this Chk1 activation model. Here we used FRET and bimolecular fluorescence complementary techniques to show that Chk1 indeed maintains a closed conformation in the absence of DNA damage through an intramolecular interaction between a region (residues 31-87) at the N-terminal kinase domain and the distal C terminus. A highly conserved Leu-449 at the C terminus is important for this intramolecular interaction. We further showed that abolishing the intramolecular interaction by a Leu-449 to Arg mutation or inducing ATR-dependent Chk1 phosphorylation by DNA damage disrupts the closed conformation, leading to an open and activated conformation of Chk1. These data provide significant insight into the mechanisms of Chk1 activation during the DNA damage response.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DNA damage; checkpoint control; molecular cell biology; phosphorylation; protein conformation

Mesh:

Substances:

Year:  2016        PMID: 27129240      PMCID: PMC4933214          DOI: 10.1074/jbc.M115.713248

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Monitoring protein conformations and interactions by fluorescence resonance energy transfer between mutants of green fluorescent protein.

Authors:  A Miyawaki; R Y Tsien
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  S phase and G2 arrests induced by topoisomerase I poisons are dependent on ATR kinase function.

Authors:  William A Cliby; Kriste A Lewis; Kia K Lilly; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2001-11-07       Impact factor: 5.157

3.  UbcH7 regulates 53BP1 stability and DSB repair.

Authors:  Xiangzi Han; Lei Zhang; Jinsil Chung; Franklin Mayca Pozo; Amanda Tran; Darcie D Seachrist; James W Jacobberger; Ruth A Keri; Hannah Gilmore; Youwei Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

4.  The topoisomerase I poison camptothecin generates a Chk1-dependent DNA damage checkpoint signal in fission yeast.

Authors:  S Wan; H Capasso; N C Walworth
Journal:  Yeast       Date:  1999-07       Impact factor: 3.239

5.  Coupling cellular localization and function of checkpoint kinase 1 (Chk1) in checkpoints and cell viability.

Authors:  Jingna Wang; Xiangzi Han; Xiujing Feng; Zhenghe Wang; Youwei Zhang
Journal:  J Biol Chem       Date:  2012-06-11       Impact factor: 5.157

6.  Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control.

Authors:  Deborah Wilsker; Eva Petermann; Thomas Helleday; Fred Bunz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-17       Impact factor: 11.205

7.  The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas.

Authors:  Lieve Verlinden; Isabelle Vanden Bempt; Guy Eelen; Maria Drijkoningen; Ilse Verlinden; Kathleen Marchal; Christiane De Wolf-Peeters; Marie-Rose Christiaens; Luc Michiels; Roger Bouillon; Annemieke Verstuyf
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

8.  Conserved ATRMec1 phosphorylation-independent activation of Chk1 by single amino acid substitution in the GD domain.

Authors:  Elizabeth Pereira; Yinhuai Chen; Yolanda Sanchez
Journal:  Cell Cycle       Date:  2009-06-15       Impact factor: 4.534

9.  KA1-targeted regulatory domain mutations activate Chk1 in the absence of DNA damage.

Authors:  Eun-Yeung Gong; Veronique A J Smits; Felipe Fumagallo; Desiree Piscitello; Nick Morrice; Raimundo Freire; David A Gillespie
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

10.  Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer.

Authors:  Katja Lundgren; Karolina Holm; Bo Nordenskjöld; Ake Borg; Göran Landberg
Journal:  Breast Cancer Res       Date:  2008-09-29       Impact factor: 6.466

View more
  9 in total

1.  Hydroxyurea Induces Cytokinesis Arrest in Cells Expressing a Mutated Sterol-14α-Demethylase in the Ergosterol Biosynthesis Pathway.

Authors:  Yong-Jie Xu; Amanpreet Singh; Gerald M Alter
Journal:  Genetics       Date:  2016-08-31       Impact factor: 4.562

2.  Intramolecular autoinhibition of checkpoint kinase 1 is mediated by conserved basic motifs of the C-terminal kinase-associated 1 domain.

Authors:  Ryan P Emptage; Megan J Schoenberger; Kathryn M Ferguson; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

3.  Exploration of the molecular mechanisms of cervical cancer based on mRNA expression profiles and predicted microRNA interactions.

Authors:  Liang Zhao; Zhechao Zhang; Hongyan Lou; Jingjing Liang; Xiaojian Yan; Wenfeng Li; Yunsheng Xu; Rongying Ou
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

4.  An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication.

Authors:  Tatiana N Moiseeva; Yandong Yin; Michael J Calderon; Chenao Qian; Sandra Schamus-Haynes; Norie Sugitani; Hatice U Osmanbeyoglu; Eli Rothenberg; Simon C Watkins; Christopher J Bakkenist
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-17       Impact factor: 12.779

5.  Chk1-mediated phosphorylation of Cdh1 promotes the SCFβTRCP-dependent degradation of Cdh1 during S-phase and efficient cell-cycle progression.

Authors:  Adrian E Torres; Benjamin R Stromberg; Debjani Pal; Abbey L Messina; Andrew S Dickson; Kuntal De; Belinda Willard; Monica Venere; Matthew K Summers
Journal:  Cell Death Dis       Date:  2020-04-28       Impact factor: 8.469

6.  Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.

Authors:  Cristina Nieto-Jimenez; Ana Alcaraz-Sanabria; Sandra Martinez-Canales; Veronica Corrales-Sanchez; Juan Carlos Montero; Miguel Burgos; Miriam Nuncia-Cantarero; Atanasio Pandiella; Eva M Galan-Moya; Alberto Ocaña
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

7.  Probing Interdomain Linkers and Protein Supertertiary Structure In Vitro and in Live Cells with Fluorescent Protein Resonance Energy Transfer.

Authors:  Sujit Basak; Nabanita Sakia; Laura Dougherty; Zhuojun Guo; Fang Wu; Frank Mindlin; Jeffrey W Lary; James L Cole; Feng Ding; Mark E Bowen
Journal:  J Mol Biol       Date:  2021-01-01       Impact factor: 5.469

8.  A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells.

Authors:  Andrew J Massey
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

9.  Maternal heterozygous mutation in CHEK1 leads to mitotic arrest in human zygotes.

Authors:  Beili Chen; Jianying Guo; Ting Wang; Qianhui Lee; Jia Ming; Fangfang Ding; Haitao Li; Zhiguo Zhang; Lin Li; Yunxia Cao; Jie Na
Journal:  Protein Cell       Date:  2021-05-04       Impact factor: 14.870

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.